Pharmacological trials: primary and secondary prevention of coronary heart disease

This publication has 11 references indexed in Scilit:

• COLESTIPOL PLUS NICOTINIC ACID IN TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA
  The Lancet, 1981
• Normalization of Low-Density-Lipoprotein Levels in Heterozygous Familial Hypercholesterolemia with a Combined Drug Regimen
  New England Journal of Medicine, 1981
• Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group.
  Circulation, 1980
• A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.
  Heart, 1978
• Gallbladder Disease as a Side Effect of Drugs Influencing Lipid Metabolism Experience in the Coronary Drug Project
  New England Journal of Medicine, 1977
• Regression and Progression of Early Femoral Atherosclerosis in Treated Hyperlipoproteinemic Patients
  Annals of Internal Medicine, 1977
• Clofibrate and niacin in coronary heart disease
  JAMA, 1975
• The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research Group
  Published by American Medical Association (AMA) ,1973
• The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group
  Published by American Medical Association (AMA) ,1972
• The Coronary Drug Project. Initial findings leading to modifications of its research protocol
  JAMA, 1970